CIL-05

N/A

Report date: 2025/10/15 18:06:35
NME

Base Information

Drug NameCIL-05
Drug Alias NameCIL-05
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveCiliary Motility DisordersBronchiectasis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCila Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCila Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveCiliary Motility DisordersBronchiectasis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A